Status:
COMPLETED
TLESR-impedance Study in Patients
Lead Sponsor:
AstraZeneca
Conditions:
Reflux Episodes
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
The purpose of the study is to compare frequency and content of reflux episodes in patients with gastroesophageal reflux disease.
Eligibility Criteria
Inclusion
- Provision of written consent
- GERD patients, age 18-70 years, females must be postmenopausal or surgically sterilised
- 6 months history of GERD and incomplete response to PPI treatment
Exclusion
- Insufficient symptom burden of the reflux disease evaluated by questionnaires
- S-creatinine \>1.2 times upper limit of normal
- History of heart disease
- Prior surgery of the upper GI tract
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00743444
Start Date
February 1 2007
End Date
February 1 2008
Last Update
July 22 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.